To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Second-generation TKI das… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Second-generation TKI dasatinib inhibits proliferation of mesenchymal stem cells and osteoblast differentiation in vitro.

Journal article
Authors Sofia Jönsson
H Hjorth-Hansen
Bob Olsson
Hans Wadenvik
A Sundan
T Standal
Published in Leukemia
Volume 24
Issue 7
Pages 1357-9
ISSN 1476-5551
Publication year 2010
Published at Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Institute of Medicine, Department of Internal Medicine
Pages 1357-9
Language en
Links dx.doi.org/10.1038/leu.2010.84
Keywords Blotting, Western, Bone Morphogenetic Proteins, metabolism, Cell Differentiation, drug effects, Cell Proliferation, drug effects, Cells, Cultured, Humans, Mesenchymal Stromal Cells, drug effects, Osteoblasts, cytology, drug effects, Osteogenesis, Protein Kinase Inhibitors, pharmacology, Protein-Tyrosine Kinases, antagonists & inhibitors, Pyrimidines, pharmacology, RNA, Messenger, genetics, Reverse Transcriptase Polymerase Chain Reaction, Thiazoles, pharmacology
Subject categories Clinical Medicine
Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?